Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2021 2
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.
Hoenigl M, Salmanton-García J, Egger M, Gangneux JP, Bicanic T, Arikan-Akdagli S, Alastruey-Izquierdo A, Klimko N, Barac A, Özenci V, Meijer EFJ, Khanna N, Bassetti M, Rautemaa-Richardson R, Lagrou K, Adam KM, Akalin EH, Akova M, Arsic Arsenijevic V, Aujayeb A, Blennow O, Bretagne S, Danion F, Denis B, de Jonge NA, Desoubeaux G, Drgona L, Erben N, Gori A, García Rodríguez J, Garcia-Vidal C, Giacobbe DR, Goodman AL, Hamal P, Hammarström H, Toscano C, Lanternier F, Lass-Flörl C, Lockhart DEA, Longval T, Loughlin L, Matos T, Mikulska M, Narayanan M, Martín-Pérez S, Prattes J, Rogers B, Rahimli L, Ruiz M, Roilides E, Samarkos M, Scharmann U, Sili U, Sipahi OR, Sivakova A, Steinmann J, Trauth J, Turhan O, Van Praet J, Vena A, White PL, Willinger B, Tortorano AM, Arendrup MC, Koehler P, Cornely OA; ECMM Candida III Study Group. Hoenigl M, et al. Among authors: akalin eh. Lancet Infect Dis. 2023 Jun;23(6):751-761. doi: 10.1016/S1473-3099(22)00872-6. Epub 2023 Feb 15. Lancet Infect Dis. 2023. PMID: 37254300 Free article.
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial.
Tanriover MD, Aydin OA, Guner R, Yildiz O, Celik I, Doganay HL, Kose S, Akhan S, Akalin EH, Sezer Z, Ozdarendeli A, Unal S, On Behalf Of The Turkovac Study Group. Tanriover MD, et al. Among authors: akalin eh. Vaccines (Basel). 2022 Nov 4;10(11):1865. doi: 10.3390/vaccines10111865. Vaccines (Basel). 2022. PMID: 36366373 Free PMC article.
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
Tanriover MD, Doğanay HL, Akova M, Güner HR, Azap A, Akhan S, Köse Ş, Erdinç FŞ, Akalın EH, Tabak ÖF, Pullukçu H, Batum Ö, Şimşek Yavuz S, Turhan Ö, Yıldırmak MT, Köksal İ, Taşova Y, Korten V, Yılmaz G, Çelen MK, Altın S, Çelik İ, Bayındır Y, Karaoğlan İ, Yılmaz A, Özkul A, Gür H, Unal S; CoronaVac Study Group. Tanriover MD, et al. Among authors: akalin eh. Lancet. 2021 Jul 17;398(10296):213-222. doi: 10.1016/S0140-6736(21)01429-X. Epub 2021 Jul 8. Lancet. 2021. PMID: 34246358 Free PMC article. Clinical Trial.
13 results